Clinical trial Recruiting at 1 site Observational Ages 18 and up

Surgical fixation for hip fractures in patients on blood thinners

Official title: Early Surgical Fixation of Low-Velocity Hip Fractures in Patients With Direct Oral Anticoagulation

Run by Medical University of Vienna · NCT05070169 · Data updated 2026-11-12

This study is testing if fixing hip fractures quickly in patients on blood thinners can reduce blood loss and improve survival rates compared to those who have surgery later.

More Hip Fractures trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment140 (estimated)
SponsorMedical University of Vienna
Academic / other
Locations1 site (Vienna)
StatusRecruiting
StartedOctober 15, 2021
Main results expectedSeptember 15, 2025
Study endsDecember 31, 2025
Registry record updatedNovember 25, 2024
Trial IDNCT05070169 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with intertrochanteric fractures requiring surgical fixation while on DOAC medication.

Probably not a fit

Patients with multiple fractures or significant comorbidities that prevent prompt surgical fixation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines patients with intertrochanteric hip fractures who are receiving direct oral anticoagulation (DOAC) therapy and undergo early surgical fixation within 24 hours of injury. The primary goal is to evaluate the reduction in perioperative blood loss associated with early fixation. Additionally, the study aims to assess the impact of early surgical intervention on 30-day and 1-year mortality rates compared to a control group that received delayed fixation. The cohort will be compared to a matched group of patients who had delayed surgery from 2014 to 2018.

Why it matters

Potential benefit: If successful, this approach could lead to reduced blood loss and improved survival rates for patients with hip fractures on anticoagulation therapy.

How similar studies have gone: While similar studies have explored surgical timing in fracture management, this specific approach in patients on DOAC therapy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Prospective cohort study:

Patients with intertrochanteric fractures that need a surgical fixation and under treatment with a DOAC medication

Control group:

Patients with intertrochanteric fractures under DOAC medication with a delayed surgical fixation from January 2014 to December 2018 (≥ 48 hours after the trauma)

Exclusion Criteria:

Prospective cohort group:

* patients with multiple fractures
* acute heart failure, kidney and lung failure and
* other concomitant diseases which prevent prompt fixation

Retrospective cohort group:

Patients with delayed surgical fixation due to other causes than DOAC medication (e.g. multimorbidity, acute myocardial infarction, acute heart, lung or kidney failure)

Where it's running

  • Medical University of Vienna, Department of Traumatology
    Vienna, Austria
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.